From the experts: Top 3 trends in skin microbiome research

From the experts Top 3 trends in skin microbiome research

As reported by market research firm Statista, “as the global population grows and the importance of skin care becomes better known, the global skin care market is projected to increase from $143.5 bn in 2022 to over $186 bn by 2028.” A growing sector of the skin care market is focused on the skin microbiome and products that facilitate skin health by addresses the delicate balance of the face’s ecosystem.

Over the last several years, the skin microbiome the skin microbiome has continued to emerge as a focal point of research and innovation. We spoke to Dr. Oliver Worsley, CEO and Co-Founder of Sequential – The Skin Microbiome Testing Co., as he sheds light on the top three trends currently dominating the space.  

From the increasing adoption of clinical in vivo testing to the exploration of host-microbial interactions and the potential of new technologies like nanoparticles, these advancements are poised to redefine cosmetics and personal care product manufacturers and suppliers approach skin care product formulation R&D. In his interview, Dr. Worsley also highlights how these trends are driving product development strategies, fostering personalization, and leading to groundbreaking collaborations within the industry.

CDU: From your perspective, what are the top three current trends in skin microbiome research that are particularly relevant to the cosmetics and personal care industry? 

Dr. Oliver Worsley (OW)​: I would describe the top three current trends in skin microbiome research as follows:

  1. Marketing trends on the microbiome in personal care, by data percentage found in marketing research exhibitions, clinical microbiome / in vivo testing increase in uptake shows that 71.4% of individuals we have spoken with feel the only way to test a formulation that confers benefit to the microbiome should be tested in vivo​, and 57.1% of individuals feel that the microbiome is not a passing trend, but a defining direction for the personal care industry. 
  2. Host-microbial interaction, or the evaluation of both human cells to understand inflammation and microbial interaction with skin), including methods of detection i.e. metabolomics, and
  3. New technologies to target the human microbiome to treat dysbiosis – are nanoparticles the next frontier?

Source link

About The Author

Scroll to Top